Pathstone Family Office’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $102K | Sell |
|
|||||
|
2023
Q2 | $226K | Sell |
|
|||||
|
2023
Q1 | $207K | Sell |
|
|||||
|
2022
Q4 | $326K | Sell |
|
|||||
|
2022
Q3 | $254K | Buy |
|
|||||
|
2022
Q2 | $99.9K | Buy |
|
|||||
|
2022
Q1 | $94K | Sell |
|
|||||
|
2021
Q4 | $212K | Buy |
|
|||||
|
2021
Q3 | $228K | Buy |
|
|||||
|
2021
Q2 | $264K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $39K | Buy |
|